Insider · CIK 0001394875

Labrucherie Gil M

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001394875

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-06	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2025-11-19	RZLTRezolute, Inc.A Award	Director	AAward	+21K sh	—	—	55,500
2025-11-19	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2025-08-07	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+37.5K sh	—	—	37,500
2025-06-10	RZLTRezolute, Inc.A Award	Director	AAward	+9,000 sh	—	—	34,500
2025-06-10	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-02-27	SEPNSepterna, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,718 sh	$5.85	+$21.8K	40,000
2025-02-25	SEPNSepterna, Inc.P Purchase	Chief Financial Officer	PPurchase	+6,282 sh	$5.59	+$35.1K	36,282
2025-02-21	SEPNSepterna, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$5.85	+$29.3K	30,000
2025-02-20	SEPNSepterna, Inc.P Purchase	Chief Financial Officer	PPurchase	+14.5K sh	$5.88	+$85.2K	25,000
2025-02-19	SEPNSepterna, Inc.P Purchase	Chief Financial Officer	PPurchase	+10.5K sh	$5.51	+$57.8K	10,500
2025-02-16	RZLTRezolute, Inc.A Award	Director	AAward	+25.5K sh	—	—	25,500
2025-02-16	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-02-07	SEPNSepterna, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+222K sh	—	—	222,000
2024-08-31	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+150K sh	—	—	150,000
2024-05-23	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+184K sh	—	—	184,042
2024-01-23	RZLTRezolute, Inc. · Director Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-01-09	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+856K sh	—	—	855,513
2023-10-04	ACELYRIN, Inc.J Other	CFO and CBO	JOther	+40.8K sh	—	—	40,763
2023-08-17	ACELYRIN, Inc.Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+255K sh	—	—	254,939
2022-06-23	RZLTRezolute, Inc. · Stock Option (right to buy)A Award	Director	AAward	+80K sh	—	—	80,000
2022-05-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−17.4K sh	$3.95	−$68.9K	312,905
2022-05-15	NKTRNEKTAR THERAPEUTICSA Award	SVP, COO & CFO	AAward	+28.8K sh	—	—	330,353
2022-05-04	RZLTRezolute, Inc.P Purchase	Director	PPurchase	+52.6K sh	$3.80	+$200K	52,631
2022-05-04	RZLTRezolute, Inc.P Purchase	Director	PPurchase	+52.6K sh	$3.80	+$200K	53,572
2022-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−7,579 sh	$10.95	−$83K	301,603
2021-12-16	NKTRNEKTAR THERAPEUTICSA Award	SVP, COO & CFO	AAward	+53K sh	—	—	309,182
2021-12-16	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP, COO & CFO	AAward	+94K sh	—	—	94,000
2021-11-18	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−3,000 sh	$12.69	−$38.1K	256,682
2021-11-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−21.1K sh	$13.16	−$278K	259,682
2021-11-15	NKTRNEKTAR THERAPEUTICSA Award	SVP, COO & CFO	AAward	+40.2K sh	—	—	280,831
2021-10-12	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	SVP, COO & CFO	AAward	+71.6K sh	—	—	71,550
2021-08-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−3,000 sh	$13.56	−$40.7K	240,231
2021-08-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−7,867 sh	$13.83	−$109K	243,231
2021-06-14	RZLTRezolute, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-05-17	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−7,898 sh	$18.30	−$145K	251,098
2021-02-16	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−7,977 sh	$22.37	−$178K	258,996
2021-02-04	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	+50K sh	$8.80	+$440K	316,973
2021-02-04	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−50K sh	$19.81	−$990K	266,973
2021-02-04	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	−50K sh	—	—	0
2021-02-03	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	+25K sh	$8.80	+$220K	291,973
2021-02-03	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	+25K sh	$8.80	+$220K	316,973
2021-02-03	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−50K sh	$19.61	−$981K	266,973
2021-02-03	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	−25K sh	—	—	0
2021-02-03	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	−25K sh	—	—	50,000
2021-02-02	NKTRNEKTAR THERAPEUTICSM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	+50K sh	$8.80	+$440K	316,973
2021-02-02	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−41.1K sh	$19.97	−$821K	275,838
2021-02-02	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−6,932 sh	$20.96	−$145K	268,906
2021-02-02	NKTRNEKTAR THERAPEUTICSS Sale	SVP, COO & CFO	SSale	−1,933 sh	$21.66	−$41.9K	266,973
2021-02-02	NKTRNEKTAR THERAPEUTICS · Stock OptionM Exercise/Conversion	SVP, COO & CFO	MExercise/Conversion	−50K sh	—	—	25,000

Recent filings

Accepted (ET)
Feb 104
Labrucherie Gil M0001193125-26-045109
SEC(opens sec.gov)
Nov 214
Labrucherie Gil M0000912282-25-001279
SEC(opens sec.gov)
Aug 114
Labrucherie Gil M0000950170-25-106795
SEC(opens sec.gov)
Jun 134
Labrucherie Gil M0000912282-25-000664
SEC(opens sec.gov)
Feb 274
Labrucherie Gil M0000950170-25-029330
SEC(opens sec.gov)
Feb 214
Labrucherie Gil M0000950170-25-025039
SEC(opens sec.gov)
Feb 204
Labrucherie Gil M0000912282-25-000184
SEC(opens sec.gov)
Feb 74
Labrucherie Gil M0000950170-25-016362
SEC(opens sec.gov)
Sep 44
Labrucherie Gil M0001962918-24-000112
SEC(opens sec.gov)
May 244
Labrucherie Gil M0001962918-24-000065
SEC(opens sec.gov)
Jan 254
Labrucherie Gil M0000912282-24-000079
SEC(opens sec.gov)
Jan 114
Labrucherie Gil M0001962918-24-000004
SEC(opens sec.gov)
Oct 64
Labrucherie Gil M0001962918-23-000034
SEC(opens sec.gov)
Aug 214
Labrucherie Gil M0001962918-23-000029
SEC(opens sec.gov)

Companies

Address

C/O SEPTERNA, INC. 250 EAST GRAND AVENUE

SOUTH SAN FRANCISCO, CA, 94080